J & amp;J Fires up the Surgical Robotics Market with New Verb Deal

Earlier this year, MD+DI asked if Johnson & Johnson was becoming a surgical robotics powerhouse. This seems to be the case now that the New Brunswick, N.J.-based company has said it will acquire the remaining stake in the Verb Surgical joint venture it has with Verily. The companies did not disclose the financial details of deal, which is expected to close in the first half of 2020. In a release, J&J’s Worldwide Chairman, Medical Devices Ashley McEvoy said, "We have reached this important milestone thanks to the progress the Verb Surgical team has made with their digital surgery platform and the strong collaboration with Verily, Ethicon, and the clinicians around the world who shared their passion, deep insights, and clinical expertise. We are building a truly differentiated digital surgery ecosystem to change the standard of care for generations to come, and our collaboration with Verily has enabled us to advance our vision to help improve outcomes for patients around the world." J&J has been slowly but surely becoming a major force to be reckoned with in surgical robotics. The company made a significant end toward this goal when it announced it would acquire Auris Health for $3.4 billion with $2.35 billion in milestones. The Redwood City, CA-based company was developing the Monarch Platform, an FDA cleared system currently used in bronchoscopic diagnostic and therapeutic procedures. In addition to the device, J&J was able to bring surgical ...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Digital Health Source Type: news